Introduced
by
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments.
Referred to the Committee on Insurance
Reported without amendment
With the recommendation that the substitute (H-1) be adopted and that the bill then pass.
Passed in the House 91 to 15 (details)
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to ban charging a copay of more than $150 per month on these drugs.
Referred to the Committee on Health Policy and Human Services
